Literature DB >> 27939027

Prevalence of obesity according to Edmonton staging in the Internal Medicine consultations. Results of the OBEMI study.

J Carretero Gómez1, J C Arévalo Lorido2, R Gómez Huelgas3, M T Sánchez Vidal4, M Suárez Tembra5, J M Varela Aguilar6, I Munielo Voces7, E Fernández Pérez7, J M Fernández Rodríguez8, J Ena Muñoz9.   

Abstract

OBJECTIVES: To estimate the prevalence of obesity in patients treated by departments of Internal Medicine and to classify the patients according to the Edmonton Obesity Staging System (EOSS).
MATERIAL AND METHODS: An observational, descriptive cross-sectional study included outpatients older than 18 years, with a body mass index (BMI)>30, from 38 hospitals between the 1st and 14th of February, 2016. We classified the patients according to the EOSS and analysed their clinical, laboratory and demographic variables. A value of P<.05 was considered statistically significant.
RESULTS: Of the 1,262 patients treated in consultations, we recruited 298 and analysed 265. The prevalence of obesity was 23.6%, the mean age was 62.47±15.27 years, and the mean BMI was 36.1±5.3kg/m2. According to EOSS stage (0, 1, 2, 3 and 4), the prevalence was 4.9, 14.7, 62.3, 15.5 and 2.64%, respectively. Those patients with EOSS>2 were significantly older and had significantly more comorbidities. The multivariate analysis related age (OR 1.06; P<.0003), blood glucose (OR 1.04; P<.0006), total cholesterol (OR 0.98; P<.02) and uric acid (OR 1.32; P<.02) levels with an EOSS>2. An analysis of correspondence grouped, with an explanatory percentage of 78.2%, the patients according to their EOSS, comorbidity, education level, employment status and functional capacity.
CONCLUSIONS: The prevalence of obesity in the patients treated by Internal Medicine departments is similar to that of the general population, although the patients are older and have a higher BMI. EOSS is useful for implementing a comprehensive approach for patients with obesity, regardless of the BMI, which can help achieve better health and quality-of-life results.
Copyright © 2016 Elsevier España, S.L.U. and Sociedad Española de Medicina Interna (SEMI). All rights reserved.

Entities:  

Keywords:  Comorbidities; Comorbilidades; Edmonton; Obesidad; Obesity; Prevalence; Prevalencia

Year:  2016        PMID: 27939027     DOI: 10.1016/j.rce.2016.11.003

Source DB:  PubMed          Journal:  Rev Clin Esp (Barc)        ISSN: 2254-8874


  3 in total

1.  Clinical Use of the Edmonton Obesity Staging System for the Assessment of Weight Management Outcomes in People with Class 3 Obesity.

Authors:  Raymond Kodsi; Ritesh Chimoriya; David Medveczky; Kathy Grudzinskas; Evan Atlantis; Abd A Tahrani; Nic Kormas; Milan K Piya
Journal:  Nutrients       Date:  2022-02-24       Impact factor: 5.717

2.  Obesity and Bariatric Surgery in Australia: Future Projection of Supply and Demand, and Costs.

Authors:  Sithara Wanni Arachchige Dona; Mary Rose Angeles; Dieu Nguyen; Lan Gao; Martin Hensher
Journal:  Obes Surg       Date:  2022-07-08       Impact factor: 3.479

3.  High-Risk Obesity Phenotypes: Target for Multimorbidity Prevention at the ROFEMI Study.

Authors:  Juana Carretero-Gómez; Pablo Pérez-Martínez; José Miguel Seguí-Ripoll; Francisco Javier Carrasco-Sánchez; Nagore Lois Martínez; Esther Fernández Pérez; Onán Pérez Hernández; Miguel Ángel García Ordoñez; Candelaria Martín González; Juan Francisco Vigueras-Pérez; Francesc Puchades; María Cristina Blasco Avaria; María Isabel Pérez Soto; Javier Ena; José Carlos Arévalo-Lorido
Journal:  J Clin Med       Date:  2022-08-09       Impact factor: 4.964

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.